West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 190,600 | 175,000 | 161,900 | 143,200 | 107,000 |
| Marketable Securities | 7,500 | 8,200 | 12,400 | 21,900 | 25,500 |
| Receivables | 195,300 | 189,000 | 175,000 | 182,900 | 185,000 |
| Inventories | 176,500 | 173,500 | 162,200 | 165,900 | 159,200 |
| Income taxes - deferred | 9,600 | 8,900 | 7,700 | 7,400 | 7,400 |
| Other current assets | 33,800 | 35,100 | 38,100 | 36,000 | 32,900 |
| TOTAL | $613,300 | $589,700 | $557,300 | $557,300 | $517,000 |
| Non-Current Assets | |||||
| PPE Net | 663,400 | 658,500 | 669,000 | 637,000 | 620,300 |
| Investments And Advances | 58,000 | 55,600 | 59,800 | 60,700 | 57,500 |
| Intangibles | 160,800 | 160,900 | 163,100 | 162,400 | 159,500 |
| Other Non-Current Assets | 117,200 | 112,400 | 114,800 | 110,000 | 108,500 |
| TOTAL | $999,400 | $987,400 | $1,006,700 | $970,100 | $945,800 |
| Total Assets | $1,612,700 | $1,577,100 | $1,564,000 | $1,527,400 | $1,462,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 88,400 | 91,600 | 102,900 | 81,300 | 85,600 |
| Accrued Expenses | 50,000 | 38,200 | 56,500 | 52,900 | 48,300 |
| Other current liabilities | 48,000 | 48,600 | 46,300 | 73,200 | 73,900 |
| TOTAL | $218,700 | $208,100 | $261,800 | $275,600 | $320,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 394,700 | 428,400 | 378,800 | 362,100 | 296,400 |
| aiOther Non-Current Liabilities | 195,800 | 175,500 | 173,700 | 152,400 | 147,400 |
| TOTAL | $609,800 | $623,100 | $573,300 | $534,700 | $463,100 |
| Total Liabilities | $828,500 | $831,200 | $835,100 | $810,300 | $783,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,785 | 69,167 | 68,715 | 68,245 | 68,068 |
| Common Shares | 8,700 | 8,700 | 17,200 | 8,600 | 8,600 |
| Retained earnings | 775,300 | 745,000 | 719,900 | 711,900 | 697,100 |
| Other shareholders' equity | -91,100 | -92,200 | -75,900 | -71,800 | -88,800 |
| TOTAL | $784,200 | $745,900 | $728,900 | $717,100 | $679,500 |
| Total Liabilities And Equity | $1,612,700 | $1,577,100 | $1,564,000 | $1,527,400 | $1,462,800 |